Anu's Laboratories Ltd

₹ 0.24 0.00%

16 Mar 2015

About

Anu's Laboratories Limited manufactures and supplies drug intermediates and related products for the pharmaceutical industry.

[ edit about ]

[ add key points ]

Website BSE

Market Cap ₹ Cr.
Current Price ₹ 0.24
High / Low ₹ /
Stock P/E
Book Value ₹ 6.77
Dividend Yield 0.00 %
ROCE 11.7 %
ROE 2.28 %
Face Value ₹ 1.00

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.04 times its book value

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has low interest coverage ratio.
Company has a low return on equity of 8.50% over last 3 years.
Dividend payout has been low at 3.80% of profits over last 3 years
Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012
	83	104	146	155	198	262	256
	72	81	111	120	161	216	217
Operating Profit	11	23	35	35	36	46	40
OPM %	13%	22%	24%	23%	18%	18%	15%
	1	1	3	-0	2	-4	0
Interest	3	5	8	7	11	17	26
Depreciation	1	1	1	2	2	4	8
Profit before tax	8	18	28	26	26	21	6
Tax %	26%	26%	36%	37%	19%	37%	46%
	6	14	18	16	21	13	3
EPS in Rs				0.67			0.14
Dividend Payout %	14%	6%	7%	12%	11%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	20%
3 Years:	18%
TTM:	-2%

Compounded Profit Growth
10 Years:	%
5 Years:	-23%
3 Years:	-40%
TTM:	-76%

Stock Price CAGR
10 Years:	-1%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	12%
3 Years:	9%
Last Year:	2%

Balance Sheet

Figures in Rs. Crores

	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012
Equity Capital	5	8	8	12	24	24	24
Reserves	7	24	43	134	137	138	141
	18	27	41	41	81	97	131
	17	22	34	38	40	33	38
Total Liabilities	48	81	126	224	282	292	334
	14	21	22	27	43	94	94
CWIP	0	4	4	17	38	22	35
Investments	2	3	3	3	3	0	0
	32	53	97	178	198	176	205
Total Assets	48	81	126	224	282	292	334

Cash Flows

Figures in Rs. Crores

	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012
	-5	3	-7	-42	13	28	-10
	-6	-13	-3	-19	-40	-23	-19
	10	11	9	63	27	-4	26
Net Cash Flow	-0	2	-1	2	1	2	-3

Ratios

Figures in Rs. Crores

	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012
Debtor Days	22	26	57	146	124	77	119
Inventory Days	165	212	231	269	206	140	135
Days Payable	91	92	63	85	72	13	12
Cash Conversion Cycle	96	145	225	330	258	204	242
Working Capital Days	72	112	163	317	281	169	206
ROCE %		52%	48%	25%	17%	17%	12%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

Annual reports

DRHP